REFERENCES
- Mahmoud HH, Rivera GK, Hancock ML, . Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med. 1993;329:314–319.
- Gilchrist GS, Tubergen DG, Sathere HN, . Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Children's Cancer Group Report. J Clin Oncol. 1994;12:2594–2600.
- Bürger B, Zimmermann M, Mann G, . Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol. 2003;21:184–188.
- te Loo DMWM, Kamps WA, Van Den Berg A, . Prognostic significance of blasts in the cerebrospinal fluid without pleocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group. J Clin Oncol. 2006;24:2332–2336.
- Gajjar A, Harrison PL, Sandlund JT, . Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96:3381–3384.
- Pui CH, Campana D, Pei D, . Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–2741.
- Veerman AJ, Kamps WA, Van Den Berg H, . Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004). Lancet Oncol. 2009;10:957–966.
- Ritchey AK, Pollock BH, Lauer SJ, . Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study. J Clin Oncol. 1999;17:3745–3752.
- Barredo JC, Devidas M, Lauer SJ, . Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. J Clin Oncol. 2006;24:3142–3149.
- Eapen M, Zhang MJ, Devidas M, . Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Leukemia. 2008;22:281–286.
- Hagedorn N, Acquaviva C, Fronkova E, . Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group. Blood. 2007;110:4022–4029.
- Buonamici S, Trimarchi T, Ruocco MG, . CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature. 2009;459:1000–1004.
- Cannizzo E, Carulli G, Buda G, . Meningeal relapse in a case of B acute lymphoblastic leukemia: the role of CD56 expression. Med Sci Monit. 2009;15:CS27–CS22.
- Cario G, Izraeli S, Teichert A, . High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J Clin Oncol. 2007;25:4813–4820.
- Jeha S, Pei D, Raimondi SC, Onciu M, . Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia. 2009;23:1406–1409.
- Rocha JC, Cheng C, Liu W, . Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 2005;105:4752–4758.